Another compound, K-80003, a derivative of Sulforaphane, also inhibits colorectal cancer development through the suppression of STAT3 phosphorylation [89]; Meloxicam is recognized as a potential inhibitor of STAT3 due to its inhibitory effects on STAT3 activation [90]. Here, STAT3 is linked to colorectal cancer.